Folate-modified-chitosan-coated liposomes for tumor-targeted drug delivery

Journal of Materials Science

Volumn 48, Issue 4, 2013, Pages 1717-1728

  Yang, Kui Kun ^a   Kong, Ming ^a   Wei, Ya Nan ^a   Liu, Ya ^a   Cheng, Xiao Jie ^a   Li, Jing ^a   Park, Hyun Jin ^b   Chen, Xi Guang ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; LIPOSOMES; SPECTRUM ANALYSIS; TUMORS;

AVERAGE DIAMETER; CORE SHELL STRUCTURE; FOLATE RECEPTOR; INFRARED SPECTRUM; MODIFIED CHITOSAN; PHYSICAL STABILITY; TUMOR TARGETING; TUMOR-TARGETED DRUG DELIVERIES;

TARGETED DRUG DELIVERY;

EID: 84871808780     PISSN: 00222461     EISSN: 15734803     Source Type: Journal    
DOI: 10.1007/s10853-012-6930-0     Document Type: Article

References (46)

1. Bhosle J, Hall G (2009) Surgery (Oxford) 27:173. doi: 10.1016/j.mpsur.2009.01.006
2. Gómez-Hens A, Fernández-Romero JM (2006) Trends Anal Chem 25:167. doi: 10.1016/j.trac.2005.07.006
3. Coimbra M, Isacchi B, van Bloois L et al (2011) Int J Pharm 416:433. doi: 10.1016/j.ijpharm.2011.01.056
4. Torchilin VP (2005) Nat Rev Drug Discov 4:145
5. Harrington KJ, Syrigos KN, Vile RG (2002) J Pharm Pharmacol 54:1573. doi: 10.1211/0022357002243
6. Grit M, de Smidt JH, Struijke A, Crommelin DJA (1989) Int J Pharm 50:1. doi: 10.1016/0378-5173(89)90173-7
7. Graff A, Winterhalter M, Meier W (2001) Langmuir 17:919. doi: 10.1021/la001306m
8. Taylor TM, Davidson PM, Bruce BD, Weiss J (2005) Crit Rev Food Sci Nutr 45:587
9. Zhang L, Granick S (2006) Nano Lett 6:694
10. Mady MM, Darwish MM, Khalil S, Khalil WM (2009) Eur Biophys J 38:1127
11. Henriksen I, Smistad G, Karlsen J (1994) Int J Pharm 101:227. doi: 10.1016/0378-5173(94)90218-6
12. Liang X, Wang H, Jiang X, Chang J (2010) J Nanopart Res 12:1723. doi: 10.1007/s11051-010-9896-3
13. Chen X-G, Liu C-S, Liu C-G, Meng X-H, Lee CM, Park H-J (2006) Biochem Eng J 27:269. doi: 10.1016/j.bej.2005.08.021
14. Ghosh A, Ali M (2012) J Mater Sci 47:1196. doi: 10.1007/s10853-011-5885-x
15. Liu W, Chen G, He G, He Z, Qian Z (2011) J Mater Sci 46:6758. doi: 10.1007/s10853-011-5632-3
16. Yin W, Su R, Qi W, He Z (2012) J Mater Sci 47:2045. doi: 10.1007/s10853-011-6005-7
17. Henriksen I, Våagen SR, Sande SA, Smistad G, Karlsen J (1997) Int J Pharm 146:193. doi: 10.1016/s0378-5173(96)04801-6
18. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y (2003) J Controlled Release 86:235. doi: 10.1016/s0168-3659(02)00411-x
19. Wang H, Zhao P, Liang X et al (2010) Biomaterials 31:4129. doi: 10.1016/j.biomaterials.2010.01.089
20. Zhao P, Wang H, Yu M et al (2012) Eur J Pharm Biopharm 81:248. doi: 10.1016/j.ejpb.2012.03.004
21. Su W, Wang H, Wang S et al (2012) Int J Pharm 426:170. doi: 10.1016/j.ijpharm.2012.01.013
22. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y (1996) Pharm Res 13:896
23. Kozlova NO, Bruskovskaya IB, Okuneva IB et al (2001) Biochim Biophys Acta 1514:139
24. Guo J, Ping Q, Jiang G, Huang L, Tong Y (2003) Int J Pharm 260:167. doi: 10.1016/s0378-5173(03)00254-0
25. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y (1994) Chem Pharm Bull 42:1954
26. Bae YH (2009) J Controlled Release 133:2. doi: 10.1016/j.jconrel.2008.09. 074
27. Tanaka T, Shiramoto S, Miyashita M, Fujishima Y, Kaneo Y (2004) Int J Pharm 277:39. doi: 10.1016/j.ijpharm.2003.09.050
28. Kovář M, Mrkvan T, Strohalm J et al (2003) J Controlled Release 92:315. doi: 10.1016/s0168-3659(03)00340-7
29. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Trends Biotechnol 26:442
30. Li XB, Schluesener HJ, Xu SQ (2006) Arch Immunol Ther Exp 54:177
31. Ke C-Y, Mathias CJ, Green MA (2003) Nucl Med Biol 30:811. doi: 10.1016/s0969-8051(03)00117-3
32. Fujisawa T, Miyai H, Hironaka K et al (2012) Int J Pharm 436:564. doi: 10.1016/j.ijpharm.2012.07.024
33. Hilgenbrink AR, Low PS (2005) J Pharm Sci 94:2135. doi: 10.1002/jps.20457
34. Liu S-Q, Wiradharma N, Gao S-J, Tong YW, Yang Y-Y (2007) Biomaterials 28:1423. doi: 10.1016/j.biomaterials.2006.11.013
35. Lu Y, Low PS (2003) J Controlled Release 91:17
36. Leamon CP, Low PS (2001) Drug Discov Today 6:44. doi: 10.1016/s1359-6446(00)01594-4
37. Sabharanjak S, Mayor S (2004) Adv Drug Deliv Rev 56:1099. doi: 10.1016/j.addr.2004.01.010
38. Zhu H, Liu F, Guo J, Xue J, Qian Z, Gu Y (2011) Carbohydr Polym 86:1118. doi: 10.1016/j.carbpol.2011.05.061
39. Zhao P, Wang H, Yu M et al (2010) Pharm Res 27:1914. doi: 10.1007/s11095-010-0196-5
40. Chen J, Li S, Shen Q (2012) Eur J Pharm Sci 47:430. doi: 10.1016/j.ejps.2012.07.002
41. Wang F, Zhang D, Duan C et al (2011) Carbohydr Polym 84:1192. doi: 10.1016/j.carbpol.2011.01.017
42. Yang S-J, Lin F-H, Tsai H-M et al (2011) Biomaterials 32:2174. doi: 10.1016/j.biomaterials.2010.11.039
43. Wan A, Sun Y, Li H (2008) Int J Biol Macromol 43:415. doi: 10.1016/j.ijbiomac.2008.07.016
44. Voinova MV, Galkin VL, Kosevich AM (1990) Bioelectrochem Bioenerg 24:143. doi: 10.1016/0302-4598(90)85017-c
45. Sułkowski WW, Pentak D, Nowak K, Sułkowska A (2005) J Mol Struct 744-747:737. doi: 10.1016/j.molstruc.2004.11.075
46. Cercek L, Cercek B, Ockey CH (1973) Biophysik 10:195